Legal Opinion

Neurelis Inc. v. Califf

District Court, District of Columbia

Decided February 14, 2025No. Civil Action No. 2024-1576Published

1Opinion of the Court

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA _________________________________________ ) NEURELIS, INC., ) ) Plaintiff, ) ) v. ) ) SARA BRENNER, et al., 1 ) ) Case No. 24-cv-1576 (APM) Defendants, ) ) and ) ) AQUESTIVE THERAPEUTICS, INC., ) ) Intervenor-Defendant. ) _________________________________________ ) MEMORANDUM OPINION I. INTRODUCTION Congress enacted the Orphan Drug Act (“ODA”) to encourage pharmaceutical companies to develop treatments for rare diseases that affect a small portion of the population. Among the Act’s various economic incentives is a seven-year period of…

2Cases cited18 opinions

  1. Food & Drug Administration v. Brown & Williamson Tobacco Corp.Supreme Court of the United States · 2000
  2. Brown v. GardnerSupreme Court of the United States · 1994
  3. Bob Jones University v. United StatesSupreme Court of the United States · 1983
  4. Burrage v. United StatesSupreme Court of the United States · 2014
  5. Amer Bioscience Inc v. Thompson, Tommy G.Court of Appeals for the D.C. Circuit · 2001

13 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API